AMBI Scholarship in Science & Medicine
This article was originally published in The Rose Sheet
Executive Summary
Johnson & Johnson "ethnic" skin-care brand is accepting applications for its AMBI Scholarship in Science & Medicine, designed to "recognize, reward and support African-American and Hispanic women who have a genuine ambition to pursue careers in these respective fields" by awarding five women $10,000 each to help cover tuition costs, according to a Feb. 23 release. In particular, "non-traditional" students balancing a family, work and other professional goals who would like to return to school are invited to apply at 1www.AmbiFlawlessSkin.com through April 17. Company notes that in 2006 there were roughly 15,000 African American and 15,000 Hispanic female physicians versus more than 130,000 Caucasian female physicians. "AMBI Skincare has been used and trusted by women with richer skin tones for over 40 years to provide skincare solutions for flawless, even toned skin," the firm says. "With science being the key to the brand's success, AMBI extends its support to minority women who aspire to advance their careers in the sciences.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.